FINDINGS OF SCIENTIFIC MISCONDUCT
Release Date: July 10, 2000
NOTICE: OD-00-044
Department of Health and Human Services
Notice is hereby given that based on an investigation by the Office of
Research Integrity (ORI) and a decision by the Assistant Secretary for
Health, the U.S. Public Health Service (PHS) has made a final finding of
scientific misconduct in the following case:
Mr. Jin Qian, New Dimensions Research and Instrument, Inc.: Mr. Qian,
Executive Manager for Corporate Planning and Research, New Dimensions
Research and Instrument, Inc. (NDRI), committed scientific misconduct by
plagiarizing research results and text from other investigators in an
application to the National Institute of Neurological Disorders and Stroke
(NINDS), National Institutes of Health (NIH), for a Small Business Innovation
Research (SBIR) award, Glass-based neurochip system, 1 R43 NS39266-01.
Specifically, based on ORI’s analysis, PHS finds that Mr. Qian: (1) used
research images and descriptions posted on the Internet to create seven
figures in the application and used that material, its associated text, and
text from other publications obtained from the Internet without attribution,
(2) misrepresented research results in two of the plagiarized figures as
exemplar applications of NDRI’s proprietary technology, and (3)
misrepresented his research bibliography in that application and to ORI staff
during the investigation. These actions constitute falsifications in the
proposing of research because their collective effect was to falsify the
basis on which NIH reviewers determine whether NDRI could achieve the goals
of the proposed project.
Mr. Qian has accepted the PHS finding and has entered into a Voluntary
Exclusion Agreement with PHS in which he has voluntarily agreed for a three
(3) year period, beginning on June 12, 2000:
(1) to exclude himself from any contracting or subcontracting with any
agency of the United States Government and from eligibility for, or
involvement in, nonprocurement transactions (e.g., grants and cooperative
agreements) of the United States Government as defined in 45 C.F.R. Part 76
(Debarment Regulations),
(2) to exclude himself from serving in any advisory capacity to PHS,
including but not limited to service on any PHS advisory committee, board,
and/or peer review committee, or as a consultant.
INQUIRIES
For further information contact:
Acting Director
Division of Investigative Oversight
Office of Research Integrity
5515 Security Lane, Suite 700
Rockville, MD 20852
Telephone: (301) 443-5330
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|